Subject: Re: 2022阿斯利康 - 恩适得品牌建设及疾病教育材料制作结算单-5.4
From: "Dai, Iris" <[email-masked]>
To: 李嘉怡 <[email-masked]>
Cc: 刘煜圆 <[email-masked]>
Date: Thu, 4 May 2023 10:31:02 +0000

确认结算

获取 Outlook for iOS<https://aka.ms/o0ukef>
________________________________
发件人: 李嘉怡 <[email-masked]>
发送时间: Thursday, May 4, 2023 2:51:29 PM
收件人: Dai, Iris <[email-masked]>
抄送: 刘煜圆 <[email-masked]>
主题: 2022阿斯利康 - 恩适得品牌建设及疾病教育材料制作结算单-5.4

CAUTION: This email originated outside AstraZeneca. Do not open the attachment(s) unless you recognize the sender and know the content is safe.

Dear Iris，
附件为恩适得品牌建设及疾病教育材料制作的结算单，烦请确认下内容。
另，由于SOW进行过变更，此PO只制作和结算2套手册和5篇长图文。
如无误，请回复我“确认结算”邮件，我方会尽快开票邮寄，谢谢~

Best regards,

Luna Li

U-LINK BUSINESS SOLUTIONS, Account Executive

Add:  26F,  Merchants Plaza South Building,  No.333 North Chengdu Road, Jing'an District, Shanghai, 200041

MP:  +86 17717418640

E-mail: [email-masked]<mailto:[email-masked]>

搜索

复制